Neusdruppels Xylometazoline Hcl Htp (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. When applied to the nasal mucosa it stimulates alpha‑receptors on the blood‑vessel smooth muscle, causing vasoconstriction. This reduces blood flow and edema in the nasal lining, which opens the airway and relieves congestion.

The appropriate dose is determined by a healthcare professional based on the patient’s age, condition, and response. Typically, a few sprays per nostril are used, but the exact number and frequency should follow the prescriber’s instructions and the product label.

Safety in pregnancy and lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using this product to weigh potential benefits against any uncertain risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any necessary import documentation.

Neusdruppels contains Xylometazoline, which is comparable to other topical alpha‑adrenergic agents such as oxymetazoline. Both provide rapid decongestion, but Xylometazoline may have a slightly longer duration of action. Systemic side‑effects are minimal for both, though over‑use of any topical decongestant can lead to rebound congestion.

Store the nasal spray at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and retain it in the original packaging until use. Do not freeze the product.

The product is administered intranasally. The user should gently blow the nose, tilt the head slightly forward, and spray the recommended number of sprays into each nostril. Avoid inhaling deeply during administration to keep the medication on the nasal mucosa.

Serious risks, though rare, include severe hypertension, cardiac arrhythmias, and rebound nasal congestion (rhinitis medicamentosa) after prolonged use. Patients should discontinue the spray if they experience a rapid rise in blood pressure, palpitations, or worsening nasal blockage after several days of use.

Individuals with known hypersensitivity to Xylometazoline or any formulation component should avoid the product. It is also contraindicated in patients with severe hypertension, coronary artery disease, or those taking monoamine oxidase inhibitors unless directed by a physician.